Loading interface...

Cytotam 20 mg Tablet

Manufactured byCipla Ltd.
ContainsTamoxifen
Description
Cytotam 20 mg Tablet is used in both men and women to treat certain types of breast cancer. It also helps in minimizing the risk of developing breast cancer in women who are at higher risk of the disease. This medicine is not recommended for use in pregnant women. It is advised to discuss all the risks and benefits with the doctor before taking this medicine.

Side effects

Major & minor side effects for Cytotam 20 mg Tablet

  • Vaginal bleeding
  • Weight loss
  • Constipation
  • Pain or swelling in the legs
  • Dizziness
  • Absent, missed, or irregular periods
  • Troubled breathing
  • Decrease in the amount of urine
  • Headache
  • Hair loss or thinning of the hair
  • Loss of appetite
  • Nausea and vomiting

Uses of Cytotam 20 mg Tablet

What is it prescribed for?

  • Breast cancer
  • Ductal Carcinoma in Situ (DCIS)
  • Breast Cancer Prevention
  • Breast Cancer - Adjuvant
  • McCune-Albright Syndrome
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for this medicine to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The duration for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women due to the potential for serious adverse effects on the unborn baby. It should only be used in life-threatening conditions where the potential benefits outweigh the risks.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women due to the potential for adverse effects in the infants. Discuss the risks and benefits with your doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known history of allergy to Tamoxifen or any other inactive ingredients present in the formulation.

Pregnancy

This medicine is not recommended for use in pregnant women due to the potential for serious adverse effects on the unborn baby.

Venous thromboembolic events

This medicine is not recommended for use in patients with a known history of venous thromboembolic events (conditions associated with abnormal blood clot formation such as deep vein thrombosis, pulmonary embolism, etc.) due to an increase in the risk of such events.

Anastrozole

This medicine is not recommended for use along with Anastrozole, another medicine used for breast cancer.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women due to the potential for serious adverse effects on the unborn baby. It should only be used in life-threatening conditions where the potential benefits outweigh the risks.

Breast-feeding

This medicine is not recommended for use in breastfeeding women due to the potential for adverse effects in the infants. Discuss the risks and benefits with your doctor before taking this medicine.
General warnings

Suppression of menstruation

This medicine may cause irregular periods in some women. Discuss the risks and benefits with your doctor before taking this medicine.

Venous thromboembolism

This medicine is not recommended for use in patients with a known history of venous thromboembolic events (conditions associated with abnormal blood clot formation such as deep vein thrombosis, pulmonary embolism, etc) due to an increase in the risk of such events. Discuss the risks and benefits with your doctor before taking this medicine. Replacement with a suitable alternative might be required based on the clinical condition.

Uterus-endometrial cancer

The use of this medicine has been associated with an increase in the risk of uterine cancer. Discuss the risks and benefits with your doctor before taking this medicine. Replacement with a suitable alternative might be required based on the clinical condition.

Visual disturbances

This medicine should be used with caution in patients with or predisposed to visual disturbances due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Driving or operating machinery

The use of this medicine may cause dizziness, tiredness, or fatigue in some patients. Hence, it is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating heavy machinery if you experience any of these symptoms.

Bone mineral density

The use of this medicine may decrease bone density in some patients. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember. Skip the missed dose if it is almost the time for your next scheduled dose. Do not double the medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Carbamazepine

Erythromycin

Amiodarone

Warfarin

Ritonavir

Dexamethasone

Tranexamic Acid

Mifepristone

Disease interactions

Thromboembolism

This medicine is not recommended for use in patients with thromboembolism (a clotting disorder in which the formed clot moves from one place and lodges in another place) since it may worsen the patient's condition. Replacement with a suitable alternative may be required based on the clinical condition.

Liver disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
The combined use of this medicine with soy products may affect the action of the medicine and may stimulate tumor growth in some cases. Hence, it is advisable to avoid consuming soy products while taking this medicine.
Lab interactions
Information not available.
Take this medicine as advised by your doctor. Do not take in larger amounts than advised. It is advised to take this medicine at the same time every day. Ensure whether any clotting abnormalities are present before initiating the treatment. Consult the doctor if you experience any undesirable effects. Do not stop taking this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by preventing the action of a specific hormone (estrogen) in the breast tissue. This medicine attaches to the hormone receptors present in the breast tissue and prevents estrogen from attaching to the receptors. This helps both in the prevention and treatment of breast cancer.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Selective estrogen receptor modulators, Hormones/antineoplastics

Schedule

Schedule G

Tamoxifen Citrate Tablet USP, 10 mg and 20 mg (base)07840782Rx only [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 21 April 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=86dcde0e-347c-49e1-8b38-ad106a25c9af&type=display

Tamoxifen: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 13 July 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a682414.html

[Internet]. 2017 [cited 13 July 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/32519

Tamoxifen - DrugBank [Internet]. Drugbank.ca. 2020 [cited 4 June 2020]. Available from:

https://www.drugbank.ca/drugs/DB00675
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 4 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.